Dispensing Opioids: Decisions to Improve Medication Safety

Dispensing Opioids: Decisions to Improve Medication Safety

Dispensing opioids from your practice may provide immediate pain relief for your patients. However, dispensing is also accompanied by restrictions and requirements set out by Maryland state law. Prescribers who are dispensing opioids must login and enter data separately to the Prescription Drug Monitoring Program (PDMP). While treatment regularly involves assessment of a patient’s acute and/or chronic pain, other opportunities are presented at the point of dispensing. This includes an opportunity to discuss alternatives to opioid therapy, to assess and manage the risk of these therapies, and discussion of treatment agreements. Using interactive technologies, this module will briefly presents key points regarding counseling patients in safe use and processes to prevent diversion. The dispensing criteria for a legal opioid prescription will be reviewed so as to comply with federal law.

This online course includes a free 60 minute interactive module for dispensing physicians offering guidance in opioid dispensing practices. PDMP step-by-step instructions at the point of dispensing is provided.  This course meets the PDMP training requirements of the Maryland Department of Health and Mental Hygiene.

CE: 2.0 Contact Hours
Universal Activity Number (UAN): 0025-0000-17-037-H05-P
Expiration Date: 8/15/2020
Course Number: KE-CN#MD006
Target Audience: Physicians
Instructor: Fadia T. Shaya, PhD, MPH and Kate Jackson, MPH

Other modules in this series include:

Learning Objectives

At the end of this course, the physician prescriber will be able to:

  1. At the point of dispensing, assess and manage risks for patients who are prescribed medically-necessary opioids;
  2. Educate patients to safely use prescription opioids;
  3. Distinguish between opioid misuse and diversion prevention strategies; and
  4. Properly process prescriptions in the PDMP at the point of dispensing.

Your Instructor

Fadia T. Shaya
Professor, Department of Pharmaceutical Health Services Research
University of Maryland School of Pharmacy

View Bio

Kate Jackson
PDMP Manager
Maryland Behavioral Health Administration, DHMH

Technology Requirements

Unless otherwise noted in the course materials, the following are required to access online courses: a computer or mobile device with a stable internet connection (a broadband connection is recommended); a current internet browser such as Google Chrome, Microsoft Internet Expolorer, Mozilla® Firefox, or Apple® Safari that supports the Adobe® Flash® Player; a PDF Viewer; and the ability to view and update Microsoft Word®, Excel® and PowerPoint® documents. 

Successful Completion: Learners must complete all practice based activity components including the audiovisual presentations, post-test, and Activity Evaluation.  Participants must receive a score of at least 70% on the post-test in order to receive credit.  The post-test may be taken up to three (3) times. A link to the Activity Evaluation will be available on the confirmation once a learner has successfully completed the post-test. Statements of CE Credit will be available electronically via CPE Monitor within sixty (60) days of completion of the activity.

Disclosure and Transparency in CME/CPD:
It is MedChi’s policy to ensure the independence, transparency, balance, objectivity, scientific rigor and integrity, as well as validation of content for all CME/CPD activities we accredit. To that end, faculty must disclose to the participants any relationships with companies identified as meeting the ACCME definition of a commercial interest. In the process of the disclosure process, all faculty and planners have disclosed the presences or absence of such relationships to MedChi. MedChi has identified, evaluated and where appropriate, attempted to resolve any potential conflicts of interest. This is done through the use of content validation, the use of evidence-based data, and multi-disciplinary peer review. The information provided as disclosure to the learner, is to inform the learner and aide in judgment, not to imply that disclosed relationships will have a negative effect on a presentation.

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedChi, The Maryland State Medical Society, and The University of Maryland School of Pharmacy. MedChi is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statements:
Dispensing Opioids: Decisions to Improve Medication Safety
MedChi designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Maryland Prescription Drug Monitoring Program
MedChi designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Credit: In order to receive CME credit for participation in these modules the learner is required to complete a post-test and achieve a score of 70% or higher for each module.

Conflict of Interest Disclosure: In accordance with the University of Maryland School of Pharmacy Policy on Conflicts of Interest, faculty certify that they had no potential conflicts of interest while developing the materials for this program.

Use of Trade Names:  The trade names of the drugs and delivery systems in this module are for the purpose of product identification only. The developers of this activity do not intend to imply endorsement for any commercial products discussed.

Resource Disclosure: Resources are provided for the educational benefit of our learners.  These materials are not for distribution.

Privacy and Confidentiality: The Center for Innovative Pharmacy Solutions (CIPS) is committed to protect the privacy of our learners; CIPS complies with federal regulations regarding privacy and confidentiality.  Email addresses may be used periodically to update learners on course offerings and new learning resources.  Certain personal information will be provided to the professional certifying entity in order to issue Certificates of Credit.  No personal information will be sold to third parties.  Your Activity Evaluation responses will be analyzed in aggregate. 

Copyright: All information and materials provided are the property of and have been prepared by the University of Maryland Baltimore or have been granted permission for use by the copyright owner.  No portion of this module may be reproduced or transmitted without written permission from CIPS.  All rights reserved. 

The University of Maryland School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Refund Policy
  • A refund, less a $75 administration fee, will be made if cancellations are requested within 15 days. Other restrictions may apply.
  • Refund requests must be submitted in writing to cips@rx.umaryland.edu.
  • Refunds are not available in the following circumstances:
    • A learner has logged into a course or series;
    • Has launched course materials;
    • Course materials have been shipped; or
    • Request is made after 15 days of the ordering date.
  • Course registrations are non-transferrable.

Questions?  Review the Frequently Asked Questions page.  Can't find what you are looking for?  Contact Customer Service at cips@rx.umaryland.edu or 410-706-3381.